FDA Approves 2nd COVID-19 Vaccine
1/31/22 — The FDA has granted approval of the Moderna COVID-19 vaccine for individuals age 18 and older. The vaccine will be marketed as Spikevax. Read the FDA announcement.
1/31/22 — The FDA has granted approval of the Moderna COVID-19 vaccine for individuals age 18 and older. The vaccine will be marketed as Spikevax. Read the FDA announcement.